In this review we discuss the rationale and underlying radiobiologic concepts for hypofractionation, and review the clinical trials and ASTRO guidelines supporting hypofractionated radiation in the treatment of breast cancer.
Elaine M. Zeman, PhD
Advertisement
Articles by Elaine M. Zeman, PhD
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on CancerNetwork
1
FDA Approves Dato-DXd for Metastatic Triple-Negative Breast Cancer
2
Data Readouts to Watch at the 2026 ASCO Annual Meeting
3
Alpha DaRT Elicits 100% Local Disease Control in Pancreatic Cancer
4
Osteosarcoma Drug Earns Rare Pediatric Disease, Orphan Drug Designations
5